Lamivudine- and nevirapine- and stavudine-containing product in oromucosal dose form
RxNorm 2190791
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 2190791 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Lamivudine- and nevirapine- and stavudine-containing product in oromucosal dose form.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
PT
Designated preferred name (PT):
Lamivudine- and nevirapine- and stavudine-containing product in oromucosal dose form
(Atom ID: 11437320)
FN